Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High Risk, citing overvaluation concerns tied to its GLP-1 revenue stream. The ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina (chest pain) from heart disease.

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

As of 27 December at 10:59:07 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Even if prices rise in the coming months, drivers across the country will benefit from the Government's Fuel Finder scheme, which is set to launch by the end of 2025. Further details about the Fuel ...

We recently published an article titled Market Slump Drags Down Share Prices of These 15 Companies. In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS ...

We recently published an article titled Market Slump Drags Down Share Prices of These 15 Companies. In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands ...